Premium
INDUCTION R 2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: INTERIM ANALYSIS FROM THE PHASE 3B MAGNIFY STUDY
Author(s) -
Sharman J. P.,
Melear J. M.,
Yacoub A.,
Fanning S. R.,
Andorsky D. J.,
Nowakowski G. S.,
Rummel M. J.,
Lansigan F.,
Li J.,
Ahn J. R.,
Gharibo M.,
Coleman M.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.63_2879
Subject(s) - mantle cell lymphoma , medicine , rituximab , follicular lymphoma , lenalidomide , clinical endpoint , regimen , interim analysis , gastroenterology , phases of clinical research , marginal zone b cell lymphoma , lymphoma , population , refractory (planetary science) , surgery , oncology , clinical trial , immunology , marginal zone , b cell , multiple myeloma , physics , antibody , environmental health , astrobiology